Organization

Hospital Universitario Virgen Macarena, Sevilla, Spain

3 abstracts

Abstract
Health-related quality of life (HRQoL) and pain outcomes for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) who received abiraterone (abi) and olaparib (ola) versus (vs) abi and placebo (pbo) in the phase III PROpel trial.
Org: CHRU Besançon Hôpital J.Minjoz, Besançon, France, Centre Hospitalier de l’Université de Montréal/CRCHUM, Université de Montreal, Montreal, QC, Canada, Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, NC, Department of Urology, Keio University School of Medicine, Tokyo, Japan, Centro Integrado de Oncologia de Curitiba, Curitiba, Brazil,
Abstract
ASSOCIATION ANALYSIS IN RHEUMATOID ARTHRITIS OF GENES PREVIOUSLY ASSOCIATED TO SYSTEMIC LUPUS ERYTHEMATOSUS
Org: Hospital Clinico Universitario de Santiago, Santiago de Compostela, Hospital 12 de Octubre, Madrid, Hospital Universitario Virgen Macarena, Sevilla, Spain, Hospital Universitario de Bellvitge, Barcelona, Hospital Universitario de Valme, Sevilla,
Abstract
ASSOCIATION STUDY OF GENETIC RISK VARIANTS FOR PSORIASIS IN A LARGE COHORT OF PSORIATIC ARTHRITIS, PSORIASIS AND CONTROLS OF THE SPANISH POPULATION AND ASSOCIATION WITH RELEVANT CLINICAL SUBPHENOTYPES
Org: Hospital Clinic i Provincial de Barcelona, Barcelona, Spain, Hospital Universitario Gregorio Marañόn, Madrid, Complejo Hospitalario Juan Canalejo, A Coruña, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, Hospital Universitario de Salamanca, Salamanca,